Select for export An Investigation of Strategies to Understand and Optimize the Antidepressant Effects of Psilocybin (The OPTIMIZE Study) Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-05-22 Charles Raison ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyAging Clinical Trial More
Select for export Age and cannabis co-use moderate experience and perceived benefits of psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/dczw2_v1 Copy citation Copy BibTeX PsyArXiv 2025-05-21 Hooper J, Williams S, Mueller R, Hutchison K. PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionAnxietyAddiction Other More
Select for export Age and cannabis co-use moderate experience and perceived benefits of psilocybin Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2025-05-21 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionAnxietyAddiction Other More
Select for export Lessons learned from the regulatory alignment in ketamine, esketamine and arketamine clinical trials: A cross-sectional analysis of protocols from ClinicalTrials.gov. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.psychres.2025.116559 PubMed 40440859 Copy citation Copy BibTeX Unknown journal 2025-05-21 Swieczkowski D, Kwaśny A, Sadko K, Pruc M, Gaca Z, Szarpak L Europe PMC Published psilocybin DepressionClinical TrialTreatment-Resistant Depression Clinical Trial More
Select for export [Psilocybin in the setting of treatment-resistant unipolar depression: A case report]. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.encep.2025.02.007 PubMed 40413068 Copy citation Copy BibTeX Unknown journal 2025-05-21 Dumenil M, Cordova G, El-Hage W. Europe PMC Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.ynstr.2025.100732 PubMed 40496249 Copy citation Copy BibTeX Unknown journal 2025-05-18 Kit A, Conway K, Makarowski S, O'Regan G, Allen J, Shultz SR Europe PMC Published psilocybin DepressionAnxietyPTSD Review Article More
Select for export Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatments Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/6hjkm_v1 Copy citation Copy BibTeX PsyArXiv 2025-05-15 Basedow LA, Lottes L, Falkenberg I, Vogelbacher C, Yildiz C. PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionAgingObservational Study Observational Study More
Select for export Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatments Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2025-05-15 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionAgingObservational Study Observational Study More
Select for export Aesthetic quality of psychedelic experience is linked to insight and psychological outcomes Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyg.2025.1533055 PubMed 40443723 Copy citation Copy BibTeX Frontiers in Psychology 2025-05-14 Jake F. Hooper, Emily Gyongyosi, Kent E. Hutchison, Raeghan L. Mueller OpenAlex Published psilocybin DepressionAnxietyChronic Pain Observational Study More
Select for export Serotonergic psychedelics for depression: A comprehensive overview. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/bs.irn.2025.04.009 PubMed 40541312 Copy citation Copy BibTeX Unknown journal 2025-05-13 Wingert AM, Agnorelli C, Peill J, Reed S, Nutt DJ, Erritzoe D. Europe PMC Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Psychedelic-assisted psychotherapy and its potential to manage demoralization: A brief exploration of an alternative approach to end of life care Abstract available at the source but not redistributed here. Read at source. Details DOI 10.70462/acim.2025.1.001 Copy citation Copy BibTeX Unknown journal 2025-05-06 Jennifer Ong OpenAlex Published psilocybin DepressionPTSDEnd-of-Life Distress Other More
Select for export Exploring the Role of Psychedelics in Modulating Ego and Treating Neuropsychiatric Disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acschemneuro.5c00247 PubMed 40254808 Copy citation Copy BibTeX ACS chemical neuroscience 2025-05-06 Wang H, Wang X PubMed Published psilocybin DepressionAnxietyPTSD Other More
Select for export Michael A. Wheeler: Psychedelics and neuroimmune circuits-what a strange trip, indeed Abstract available at the source but not redistributed here. Read at source. Details DOI 10.61373/pp025k.0011 Copy citation Copy BibTeX Psychedelics. 2025-05-05 Michael A. Wheeler OpenAlex Published psilocybin DepressionAddictionMechanism of Action Other More
Select for export Psilocybin Mitigates Behavioral Despair and Cognitive Impairment in Treatment-resistant Depression Model using Wistar Kyoto Rats Abstract available at the source but not redistributed here. Read at source. Details DOI 10.21203/rs.3.rs-5493661/v1 Copy citation Copy BibTeX Research Square 2025-05-05 Wang Z, Robbins B, Zhuang R, Bruggen Rv, Sandini T, Li X Europe PMC PREPRINT (not peer reviewed) psilocybin DepressionMechanism of ActionReceptor Pharmacology Other More
Select for export A protocol for a scoping review of variations among psychedelic interventions for psychological suffering associated with the end-of-life. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0318343 PubMed 40327705 Copy citation Copy BibTeX Unknown journal 2025-05-05 Kratina S, Strike C, Schwartz R, Nayfeh A, Jopling S, Lo C Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Systematic Review More
Select for export Psychedelic therapy as relational medicine: psychosocial mechanisms in clinical and naturalistic contexts Abstract available at the source but not redistributed here. Read at source. Details DOI 10.25560/125300 Copy citation Copy BibTeX Open MIND 2025-05-03 Hannes Kettner OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export 0391 Racial/Ethnic Differences in Psychedelic Use and Sleep Satisfaction: Preliminary Findings from the Herbal Heart Study Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/sleep/zsaf090.0391 Copy citation Copy BibTeX SLEEP 2025-04-30 Denise C. Vidot, Amrit Baral, Bria-Necole Diggs, Ranya Marrakchi El Fellah, Kylee Krivijanski, Albert Garcia-Romeu OpenAlex Published psilocybin DepressionAnxietyMechanism of Action Other More
Select for export Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische Anwendung Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/a-2517-1621 Copy citation Copy BibTeX Nervenheilkunde 2025-04-30 Anna Lasch, Timo Schweikert, Eva Dora, Theresa Kolb, Hanne Lilian Schurig, Andreas Walther OpenAlex Published psilocybin Depression Other More
Select for export From molecules to meaning: unpacking the antidepressant mechanisms of psychedelic drugs. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/17512433.2025.2515866 PubMed 40470809 Copy citation Copy BibTeX Expert review of clinical pharmacology 2025-04-30 Acero VP, Flatt TA, Gooch PM, Gaughan SJ, Levin AW, Davis AK PubMed Published psilocybin DepressionPharmacologyMechanism of Action Review Article More
Select for export The benefits and harm of psychedelics in the treatment of patients with mental health and substance abuse disorders: an integrative literature review Abstract available at the source but not redistributed here. Read at source. Details DOI 10.59476/hesdia.v0i1.700 Copy citation Copy BibTeX Unknown journal 2025-04-29 Saara Susan Sevander, Marja-Liisa Rissanen OpenAlex Published psilocybin DepressionAnxietyNeuroplasticity Clinical Trial More
